Advancing medicine through cell and genetic therapies for cancer.

Plutonet is a medical biotechnology company focussing on cell and gene-based immunotherapy, located within the Multimedia Super Corridor (MSC) at Bio-X Centre, Cyberjaya, a high-tech science and research-based development centre.

They operate from Malaysia’s first Biosafety Level 2 (BSL-2) cGMP facility, in accordance to PIC/S standards by the National Pharmaceutical Regulatory Agency (NPRA), a division of Ministry of Health, Malaysia.

Their team is dedicated to the development, production, and commercialization of cell and gene-based immuno-therapeutic products, with a primary focus on CAR T-cells therapy for the treatment of blood cancers and tumours.